A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements other than statements of historical fact included in this Annual Report, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 286M | 240M | 204M | 219M | 169M | 147M |
| Net Income | 12M | 11M | 19M | 738K | -6.1M | -3.7M |
| EPS | $3.94 | $3.83 | $6.38 | $0.25 | $-2.20 | $-1.33 |
| Free Cash Flow | 5.1M | 13M | 15M | -7.9M | -9.8M | -1.5M |
| ROIC | 27.2% | 48.4% | 233.9% | 11.8% | -17.1% | -8.9% |
| Gross Margin | 29.1% | 28.6% | 25.5% | 16.2% | 14.3% | 16.3% |
| Debt/Equity | 0.15 | 0.18 | 0.06 | 0.10 | 0.05 | 0.17 |
| Dividends/Share | $0.00 | - | - | - | - | $0.38 |
| Operating Income | 20M | 18M | 18M | 5.4M | -2.6M | -1.3M |
| Operating Margin | 6.9% | 7.4% | 9.0% | 2.4% | -1.5% | -0.9% |
| ROE | 16.8% | 19.1% | 34.2% | 2.0% | -17.2% | -8.9% |
| Shares Outstanding | 3M | 3M | 3M | 3M | 3M | 3M |
KEWAUNEE SCIENTIFIC CORP /DE/ passes 5 of 9 quality checks, suggesting mixed fundamentals.
KEWAUNEE SCIENTIFIC CORP /DE/ trades at 9.0x trailing earnings, compared to its 15-year median P/E of 12.8x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 8.1x vs a median of 7.7x. The company's 5-year average ROIC is 8.6% with a gross margin of 20.2%. Total shareholder yield (buybacks) is 1.6%. At current prices, the estimated annualized return to fair value is +72.6%.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a current P/E ratio of 9.0, compared to its historical median P/E of 12.8. The stock is currently considered Fair based on its historical valuation range.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a 5-year average return on invested capital (ROIC) of 8.6%. This is below average and may indicate limited pricing power.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a market capitalization of $99M. It is classified as a small-cap stock.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.62%.
Based on historical P/E analysis, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) appears fair. The current P/E of 9.0 is 30% below its historical median of 12.8. The estimated fair value CAGR (P/E method) is 31.2%.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) operates in the Laboratory Apparatus & Furniture industry, within the Technology sector.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported annual revenue of $240 million in its most recent fiscal year, based on SEC EDGAR filings.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a net profit margin of 4.7%. This is a modest margin.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) generated $13 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a debt-to-equity ratio of 0.18. This indicates a conservatively financed balance sheet.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported earnings per share (EPS) of $3.83 in its most recent fiscal year.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a return on equity (ROE) of 19.1%. This indicates the company generates strong returns for shareholders.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a 5-year average gross margin of 20.2%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 15 years of financial data for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a book value per share of $21.65, based on its most recent annual SEC filing.
No recent press releases.